154 related articles for article (PubMed ID: 37941318)
1. Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination.
Pirzadeh A; Emami S; Zuckerman JE; Nobakht N
Am J Case Rep; 2023 Nov; 24():e941621. PubMed ID: 37941318
[TBL] [Abstract][Full Text] [Related]
2. Minimal change disease following the Moderna COVID-19 vaccine: first case report.
Thappy S; Thalappil SR; Abbarh S; Al-Mashdali A; Akhtar M; Alkadi MM
BMC Nephrol; 2021 Nov; 22(1):376. PubMed ID: 34763669
[TBL] [Abstract][Full Text] [Related]
3. Relapse of minimal change disease following the third mRNA COVID-19 vaccination: a case report and literature review.
Teragaki M; Tanaka M; Yamamoto H; Watanabe T; Takeoka J; Fukumi A; Maeda K; Takami Y; Saita H; Iwanari S; Ikeda M; Takeoka H
CEN Case Rep; 2024 Feb; 13(1):53-58. PubMed ID: 37244881
[TBL] [Abstract][Full Text] [Related]
4. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review.
Lim JH; Han MH; Kim YJ; Kim MS; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
J Korean Med Sci; 2021 Aug; 36(30):e218. PubMed ID: 34342187
[TBL] [Abstract][Full Text] [Related]
5. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y
Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200
[TBL] [Abstract][Full Text] [Related]
6. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation?
Annicchiarico Petruzzelli L; Minale B; Serio V; De Luca A; Marino Marsilia G; Campione S; Diomedi Camassei F; D'Arcangelo R; Luongo I; Lepore L; Giannattasio P; Molino D; Pirro L; Lonardo MC; Malgieri G; Pecoraro C
G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655832
[TBL] [Abstract][Full Text] [Related]
7. De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.
Marinaki S; Kolovou K; Liapis G; Skalioti C; Tsiakas S; Boletis I
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056345
[TBL] [Abstract][Full Text] [Related]
8. New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.
Nakazawa E; Uchimura T; Hirai Y; Togashi H; Oyama Y; Inaba A; Shiga K; Ito S
CEN Case Rep; 2022 May; 11(2):242-246. PubMed ID: 34782983
[TBL] [Abstract][Full Text] [Related]
9. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.
Hartley JL; Bailey N; Sharma A; Shawki H
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of podocytopathies in new-onset nephrotic syndrome following COVID-19 disease: a report of 2 cases.
Gupta RK; Bhargava R; Shaukat AA; Albert E; Leggat J
BMC Nephrol; 2020 Aug; 21(1):326. PubMed ID: 32753052
[TBL] [Abstract][Full Text] [Related]
11. Minimal Change Disease After Elective Surgical Abortion: A Case Report.
Greenberg S; Jana KR; Janga KC; Kumar K
Am J Case Rep; 2021 Mar; 22():e930292. PubMed ID: 33771965
[TBL] [Abstract][Full Text] [Related]
12. New-onset minimal change disease following the Moderna COVID-19 vaccine.
Kobayashi N; Fujisawa H; Kumagai J; Tanabe M
BMJ Case Rep; 2023 Sep; 16(9):. PubMed ID: 37714559
[TBL] [Abstract][Full Text] [Related]
13. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.
Leclerc S; Royal V; Lamarche C; Laurin LP
Am J Kidney Dis; 2021 Oct; 78(4):607-610. PubMed ID: 34242687
[TBL] [Abstract][Full Text] [Related]
14. Rapidly progressive IgA nephropathy with membranoproliferative glomerulonephritis-like lesions in an elderly man following the third dose of an mRNA COVID-19 vaccine: a case report.
Morimoto N; Mori T; Shioji S; Taguchi T; Watanabe H; Sakai K; Mori K; Yamamura A; Hanioka A; Akagi Y; Fujiki T; Mandai S; Mori Y; Ando F; Susa K; Iimori S; Naito S; Sohara E; Ohashi K; Uchida S
BMC Nephrol; 2023 Apr; 24(1):108. PubMed ID: 37095451
[TBL] [Abstract][Full Text] [Related]
15. A de novo case of minimal change disease following the first dose of the Moderna mRNA-1273 SARS-CoV-2 vaccine without relapse after the second dose.
Mochizuki RI; Takahashi N; Ikenouchi K; Shoda W; Kuyama T; Takahashi D
CEN Case Rep; 2022 Nov; 11(4):477-481. PubMed ID: 35435622
[TBL] [Abstract][Full Text] [Related]
16. A child with crescentic glomerulonephritis following SARS-CoV-2 mRNA (Pfizer-BioNTech) vaccination.
Kim S; Jung J; Cho H; Lee J; Go H; Lee JH
Pediatr Nephrol; 2023 Jan; 38(1):299-302. PubMed ID: 35854121
[TBL] [Abstract][Full Text] [Related]
17. Tolerability of COVID-19 Infection and Messenger RNA Vaccination Among Patients With a History of Kawasaki Disease.
Beckley M; Olson AK; Portman MA
JAMA Netw Open; 2022 Aug; 5(8):e2226236. PubMed ID: 35960521
[TBL] [Abstract][Full Text] [Related]
18. Nephrotic syndrome due to minimal-change disease superimposed on anti-glomerular basement membrane antibody positive glomerulonephritis; a case report.
Shibata Y; Fukuoka K; Yokota R; Lee H; Sayo H; Ikegaya N; Mori K; Yamamoto J; Isomura A; Nagahama K; Shimoyamada H; Kawakami T; Komagata Y; Kaname S
BMC Nephrol; 2020 Jul; 21(1):283. PubMed ID: 32680573
[TBL] [Abstract][Full Text] [Related]
19. Abrupt worsening of occult IgA nephropathy after the first dose of SARS-CoV-2 vaccination.
Fujita Y; Yoshida K; Ichikawa D; Shibagaki Y; Yazawa M
CEN Case Rep; 2022 Aug; 11(3):302-308. PubMed ID: 34988883
[TBL] [Abstract][Full Text] [Related]
20. Report of two cases of minimal change disease following vaccination for COVID -19.
Baskaran K; Cohen AWS; Weerasinghe N; Vilayur E
Nephrology (Carlton); 2022 Jan; 27(1):111-112. PubMed ID: 34779088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
